Nanox AI, the imaging-AI company formerly known as Zebra Medical Vision, builds algorithms that flag findings in medical scans for radiologists.
Founded in Israel and now part of Nanox, the team develops FDA-cleared algorithms that detect conditions across X-ray, CT and mammography — from liver disease to fractures — and surface them directly in radiology workflows. Its technology is deployed across imaging networks and teleradiology providers, helping prioritize urgent cases and catch incidental findings. The company pairs algorithm development with large-scale clinical validation, and its portfolio is one of the widest in medical imaging AI.
Nanox AI solutions are licensed to imaging providers and health systems; pricing is agreed per deployment and imaging volume.
Radiology groups, teleradiology networks and screening programs that want systematic second-reader support across modalities.
Nanox AI supports radiology groups wanting systematic second-reader coverage across modalities.
Institutions deploy algorithms through imaging platform integrations, validating performance on local data before clinical reliance.
More consistent detection across reading volumes, and earlier action on findings that might otherwise be missed.
Algorithms integrate through imaging platforms with local validation before clinical reliance; portfolio breadth allows phased expansion across modalities.
Detection aids require radiologist oversight, and performance varies by modality and patient population.
Imaging groups value catching incidental findings that routine reading volume can miss.
Radiologists cannot unread a second opinion. Nanox AI’s breadth across modalities makes it a practical way to add systematic AI coverage without juggling a dozen vendors. Validation per modality remains essential before clinical reliance.
For radiology groups wanting breadth under one agreement, Nanox AI is pragmatic. Validate per modality, then let algorithms prioritize the reading queue.
No. It is a commercial medical-AI portfolio sold under institutional agreements.
Algorithms are integrated into imaging workflows through PACS and platform interfaces defined per deployment.
Against single-detection vendors, Nanox AI offers breadth — many findings across modalities — under one clinical agreement.